These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26179457)

  • 1. FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.
    Wu DW; Lee MC; Hsu NY; Wu TC; Wu JY; Wang YC; Cheng YW; Chen CY; Lee H
    Oncogene; 2015 Jul; 34(29):3882-3. PubMed ID: 26179457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.
    Wu DW; Lee MC; Hsu NY; Wu TC; Wu JY; Wang YC; Cheng YW; Chen CY; Lee H
    Oncogene; 2017 Sep; 36(38):5439. PubMed ID: 28714963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.
    Wu DW; Lee MC; Hsu NY; Wu TC; Wu JY; Wang YC; Cheng YW; Chen CY; Lee H
    Oncogene; 2015 May; 34(19):2546. PubMed ID: 25950371
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
    Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
    Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
    He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
    Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corrigendum] Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
    Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
    Int J Oncol; 2017 Jan; 50(1):340. PubMed ID: 27779677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
    Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
    Oncogene; 2020 Mar; 39(10):2224-2226. PubMed ID: 31819168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.
    Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
    Int J Oncol; 2016 Sep; 49(3):1260. PubMed ID: 27573164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.
    Azoulay E; Bauer PR; Mariotte E; Russell L; Knoebl P; Martin-Loeches I; Pène F; Puxty K; Povoa P; Barratt-Due A; Garnacho-Montero J; Wendon J; Munshi L; Benoit D; von Bergwelt-Baildon M; Maggiorini M; Coppo P; Cataland S; Veyradier A; Van de Louw A;
    Intensive Care Med; 2020 Mar; 46(3):570-571. PubMed ID: 31965263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
    Kang MH; Jeong KJ; Kim WY; Lee HJ; Gong G; Suh N; Győrffy B; Kim S; Jeong SY; Mills GB; Park YY
    Oncogene; 2019 May; 38(22):4427-4428. PubMed ID: 30718918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
    Nakagawa Y; Akao Y
    Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
    Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
    Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y; Sarkar FH
    Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells.
    Rahman KM; Li Y; Sarkar FH
    Nutr Cancer; 2004; 48(1):84-94. PubMed ID: 15203382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Publisher Correction: Evolution of human malaria.
    Carlton JM
    Nat Microbiol; 2018 Oct; 3(10):1188. PubMed ID: 30194345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
    Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
    Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways.
    Wang X; Chen W; Lin Y
    Biochem Biophys Res Commun; 2007 Apr; 355(3):807-12. PubMed ID: 17316570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author Correction: Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
    Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
    Acta Pharmacol Sin; 2020 Apr; 41(4):581-582. PubMed ID: 31383989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: Multiple functions of CREB-binding protein during postembryonic development: identification of target genes.
    Roy A; George S; Palli SR
    BMC Genomics; 2018 Aug; 19(1):584. PubMed ID: 30081819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Kang, K.A.; et al., Myricetin Protects Cells against Oxidative Stress-Induced Apoptosis via Regulation of PI3K/Akt and MAPK Signaling Pathways. Int. J. Mol. Sci. 2010, 11, 4348-4360.
    Kang KA; Wang ZH; Zhang R; Piao MJ; Kim KC; Kang SS; Kim YW; Lee J; Park D; Hyun JW
    Int J Mol Sci; 2015 Jan; 16(1):1482-3. PubMed ID: 25580538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.